Poulsen Joo Hanne, Clemmensen Marianne Hald, Nørgaard Lotte Stig, Dieckmann Peter
Social and Clinical Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark.
Medicines Information Center, The Hospital Pharmacy, Capital Region of Denmark, Copenhagen NV, Denmark.
Explor Res Clin Soc Pharm. 2021 Aug 5;3:100055. doi: 10.1016/j.rcsop.2021.100055. eCollection 2021 Sep.
: The increasing number of drug shortages (DSs) worldwide calls for more proactive solutions to prevent the negative impacts of DSs on patient care. Such solutions require in-depth knowledge about potential patient safety risks related to DSs, the processes of recognizing and managing DSs, the contextual setting in which DSs occur, and the actors involved. : The aim of the study is to use prospective risk assessment to identify patient safety risks in hospitals associated with the management of DSs among actors at national, regional and local level in Denmark. : Healthcare Failure Mode and Effect Analysis (HFMEA) was employed in composition with elements from the Systematic Human Error Reduction and Prediction Approach (SHERPA) and the Systems-Theoretic Accident Model and Processes (STAMP). Potential risks related to DS management across three actor levels (national, regional and local) in the Danish healthcare system were described. Each actor level consisted of six participants that were identified using a purposive sampling strategy. Processes and sub-processes related to managing critical DSs were outlined and the actors identified, prioritized and rated potential failure modes, causes and consequences related to the processes. Recommendations to mitigate failures were proposed for high risk failures modes. : Overall, a total of 167 failure modes were identified across the three actor levels. At the national level, the process of DS management consisted of 17 sub-processes, from which 71 failure modes were identified. Nine of them were rated as high risk. At regional level, 7 sub-processes and 33 failure modes were identified, of which 9 were rated as high risk. At local level, 14 sub-processes and 63 failure modes were identified, of which 32 were rated as high risk. The high-risk failures were related to a lack of IT support in the medication modules, underestimation of patient safety aspects, and insufficient personnel training and patient information. : Exploring DS management failure modes across actor levels provided an overview of interrelated failures. Potential solutions related to high risk failures were developed to ensure that actors ensure patient safety related to DS in healthcare.
全球范围内药品短缺(DSs)数量的不断增加,需要更积极主动的解决方案来预防药品短缺对患者护理产生的负面影响。此类解决方案需要深入了解与药品短缺相关的潜在患者安全风险、识别和管理药品短缺的流程、药品短缺发生的背景环境以及涉及的相关人员。
本研究的目的是通过前瞻性风险评估,识别丹麦国家、地区和地方层面参与药品短缺管理的医院中的患者安全风险。
医疗失效模式与效应分析(HFMEA)与系统性人为错误减少与预测方法(SHERPA)以及系统理论事故模型与过程(STAMP)的要素相结合使用。描述了丹麦医疗系统中三个层面(国家、地区和地方)与药品短缺管理相关的潜在风险。每个层面由六名参与者组成,这些参与者采用目的抽样策略确定。概述了与管理关键药品短缺相关的流程和子流程,并确定了相关人员,对流程中潜在的失效模式、原因和后果进行了优先级排序和评级。针对高风险失效模式提出了减轻失效的建议。
总体而言,在三个层面共识别出167种失效模式。在国家层面,药品短缺管理流程由17个子流程组成,从中识别出71种失效模式。其中9种被评为高风险。在地区层面,识别出7个子流程和33种失效模式,其中9种被评为高风险。在地方层面,识别出14个子流程和63种失效模式,其中32种被评为高风险。高风险失效与药物模块中缺乏信息技术支持、对患者安全方面的低估以及人员培训不足和患者信息不充分有关。
探索不同层面的药品短缺管理失效模式提供了相互关联失效的概述。针对高风险失效制定了潜在解决方案,以确保相关人员在医疗保健中确保与药品短缺相关的患者安全。